14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Carcinogenesis"
DOI: 10.1093/carcin/bgy008
Abstract: Metformin is a promising drug for cancer prevention and treatment, especially in the diabetic population. We aimed to test whether 14-3-3zeta affects the anticancer effect of metformin on colorectal carcinoma (CRC). In this study, we… read more here.
Keywords: anticancer effect; metformin; colorectal carcinoma; effect metformin ... See more keywords